10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group-Reference-Cited by-同舟云学术

10 years of experience with thalidomide in multiple myeloma patients: Report of the Czech Myeloma Group

Published:2013-09 Issue:9 Volume:37 Page:1063-1069
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Minarik Jiri,Sandecka Viera,Maisnar Vladimir,Gregora Evzen,Spicka Ivan,Starostka David,Plonkova Hana,Jarkovsky Jiri,Walterova Lenka,Wrobel Marek,Adamova Dagmar,Pika Tomas,Melicharova Hana,Pour Ludek,Radocha Jakub,Pavlicek Petr,Straub Jan,Gumulec Jaromir,Bacovsky Jaroslav,Adam Zdenek,Scudla Vlastimil,Hajek Roman

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Thalidomide for treatment of multiple myeloma: 10 years later;Palumbo;Blood,2008

2. Thalidomide and lenalidomide: mechanism-based potential drug combinations;Vallet;Leuk Lymphoma,2008

3. Registry of monoclonal gammopathies;Maisnar;Onkologie,2011

4. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

5. A systematic review of phase II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma;Glasmacher;Br J Haematol,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Agents for Multiple Myeloma;Cancers;2022-11-23

2. Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma – analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies;Neoplasma;2019

3. Surgery for vertebral involvement in multiple myeloma;Journal of Neurosurgical Sciences;2017-12

4. Myeloma in the Real World: What Is Really Happening?;Clinical Lymphoma Myeloma and Leukemia;2017-03

5. The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea;The Korean Journal of Internal Medicine;2015-08-27